Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Finasteride modifies 5-alpha-reductases through a two-step process, affecting inhibitor potency and possibly causing side effects.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

Testosterone increases muscle mass regardless of DHT conversion blocking.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

Moxibustion may help improve ovarian function by changing androgen levels.

Blocking androgen receptors early in life increases estrogen levels and reduces sexual motivation in male rats.

A new method was developed to measure and assess the activity and inhibition of the enzyme steroid 5α-reductase.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Finasteride doesn't affect antipyrine metabolism, so interactions with cytochrome P-450 enzyme drugs are unlikely.

Drugs for prostate enlargement and hair loss were not linked to increased risk of depression or suicide.

Insufficient androgen action in male fetuses can cause genital development issues due to genetic mutations or environmental chemicals.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Androgens may increase arrhythmias in Brugada Syndrome, while Finasteride could reduce them.

High-dose androgen therapy can help manage certain types of androgen resistance.

Oxidative stress contributes to alopecia areata, suggesting antioxidant treatments might help.

Oxidative stress may play a role in causing androgenetic alopecia.

ROXY proteins help plants respond to nitrate shortage by affecting nutrient sensing and growth.

5α-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT levels.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Blocking androgens at birth reduces sexual motivation in male rats.

5α-reductase deficiency can cause ambiguous genitalia and gender dysphoria, treatable with testosterone.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.